期刊文献+

甲状腺癌组织中VEGF与TGF-β1的表达及其意义 被引量:2

The Expression and the correlation of VEGF and TGF-β1 in thyroid cancer.
下载PDF
导出
摘要 目的探讨血管内皮生长因子(VEGF)及转化生长因子(TGF-β1)在甲状腺癌组织中的表达及其与临床病理特征的关系。方法对48例甲状腺乳头状腺癌,10例滤泡状腺癌组织标本,采用SP免疫组化染色法检测VEGF与TGF-β1的表达。结果VEGF与TGF-β1在甲状腺癌组织中表达率分别为51.7%和56.9%,且随着肿瘤体积,病灶数量,病理分期的增加和淋巴结的转移而表达增多;两者在甲状腺癌中的表达阳性率呈正相关关系。结论VEGF可促进肿瘤的增生和转移;在甲状腺癌的生长过程中,随着表达量由低到高,TGF-β1可能先起到抑制,而后促进肿瘤细胞生长的作用。 Objective To investigate the expression of vascular endothelial growth factor(VEGF) and transforming growth factor - beta 1 (TGF - β1) in thyroid cancer and the relationship between thyroid cancer clinicopatholog- ic character. Methods Immunohistochemistry was used to examine the expression of VEGF and TGF -β1 in specimens of 48 papillary thyroid cancer and 10 follicular thyroid cancer tissues. Results The expression rates of VEGF and TGF - β1 in thyroid cancer issues were 51.7% and 56.9% , respectively; the expression rate has the relationship with the tumor bulk, the quantities of focus, the pathologic staging and the lymphatic metastasis. There was a positive correlation between those two expressions existed in thyroid cancer. Conclusion VEGF may improve the cancer ceils proliferation and spreading; As increase in the expression of TGF - β1 level in thyroid cancer, TGF - β1 may act as an inhibitor in the growth,migration of the thyroid cancer at the first; and then a promoter in the development of thyroid cancer.
出处 《现代肿瘤医学》 CAS 2005年第6期750-752,共3页 Journal of Modern Oncology
关键词 血管内皮生长因子 转化生长因子Β1 甲状腺癌 vascular endothelial growth factor transforming growth factor beta 1 thyroid cancer
  • 相关文献

参考文献20

  • 1O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma dorrelates with lymph node metastasis[J]. Cancer, 2001,92(3):556~568.
  • 2Cheng WF, Chen CA, Lee CN, et al. Vascular endothelial growth factor and prognosis of cervical carcinoma[J]. Obster Gynicol, 2000, 96(5 Pt 1):721~726.
  • 3Kiyoshi M, Yongsuk Chung. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma[J]. Cancer, 1996,77(5):858~863.
  • 4Yamamoto S, Mandai M. Expression of vascular growth(VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGFlevels[J]. BrJ Cancer, 1997,1221~1227.
  • 5Yuan A, Yu CJ, Chen WJ, et al. Correlation of total VEGF Mrna and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer[J]. Int J Cancer, 2000,89(6):475~483.
  • 6梁澍,李红,李洪钧,王琦,赵瑞霞,刘祖华.甲状腺癌中VEGF表达与DNA含量、AgNOR关系的研究[J].肿瘤,1999,19(2):82-84. 被引量:10
  • 7李云龙,牛欣,李婷婷.甲状腺癌中VEGF ras-p21的表达及与淋巴结转移的关系[J].黑龙江医学,2003,27(5):330-331. 被引量:1
  • 8Lewy-Trenda I, Wierzchniewska-Lawska A. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors[J]. Pol J Pathol, 2002,53(3):129~132.
  • 9杜静.转化生长因子β的结构、受体及作用方式[J].国外医学(免疫学分册),1997,20(1):22-25. 被引量:9
  • 10Hoelting T, Zieke A, Siperstein AE, et al. Transfoming factor-beta1 is a negative regulator or differentiated thyroid cancer: studies of growth, migration, invasion, andadhesion of cultured follicular and papillary thyroid cancer cell line[J]. J Clin Endocrinol Metab,1994,79(3):806~814.

二级参考文献3

共引文献17

同被引文献16

  • 1伍石华.甲状腺癌TGF-β_1、Smad4表达及其临床病理意义[J].陕西医学杂志,2008,37(12):1675-1677. 被引量:3
  • 2董春燕,刘铁夫,戚继萍.胰腺癌组织TGF-β_1、ERK1、ERK2和c-jun的表达及意义[J].胰腺病学,2005,5(1):28-32. 被引量:4
  • 3施承松,王祥珍.转化生长因子β_1在宫颈癌组织中的表达及其意义[J].广东医学院学报,2005,23(5):515-516. 被引量:3
  • 4刘飞,姜藻.骨形态发生蛋白与肿瘤关系的研究新进展[J].实用肿瘤学杂志,2007,21(2):188-190. 被引量:2
  • 5Hao xp, Willis JE, Pretlow TG, et al. Loss of fragile histidine triad expression in coloreetal carcinomas and premalignant lesion [J]. Cancer Res, 2000,60 ( 1 ) : 18-21.
  • 6Pusztai L, Lewis CE, Lorenzen J, et al. Growth Factora:Regulation of Normal and Neoplastidc Growth[J]. J Pathol, 1993,169: 191-201.
  • 7Hazelbags, Patherson IC, Davies M, et al. TGF-beta. Acts as atum or suppress or of human malignant keratinolytes in dependently of smad4 expression and ligand-induced garrest[J]. Oncogene,2002,21(10) : 1616-1624.
  • 8Widmann C,Gibosn S, Jarpe MB, et al. Mitogen activated protein kinase: conservation of a three kinase module from yeast to human[J]. Physiol Rev, 1999,79( 1 ) : 143-180.
  • 9Lee do Y, Lee Mw, Lee HJ, etal. ERK1/z activation attenuates TRAIL-induced apoptosis through the regulation of mitochondria-dependent pathway[J]. Toxicol Invitro,2006,20(6):816-823.
  • 10Kapetanios V, Lazaris AC, Bogris P, et al. Extracellular regulated kinase-immunoreactivity increases in parallel with cervical int raepithelial neoplasia grade in cervical neoplasial[J]. Gynecol Cancer, 2008,18(3) :540-545.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部